Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07755462

A Randomized Controlled Trial Evaluating the Stability of the Distal Tibiofibular Syndesmosis With or Without Fixation of the Posterior Fragments in Bimalleolar or Equivalent Fractures

Background and Rationale:

Injury to the tibiofibular syndesmosis in ankle fractures is a major prognostic factor for the development of post-traumatic osteoarthritis. The syndesmosis is frequently involved when posterior tibial marginal fragments are fractured. Intraoperative stability testing determines whether a trans-syndesmotic device (screws, endobutton, or plate) is required. However, trans-syndesmotic devices carry risks such as malreduction, hardware removal, and infection. Anatomical fixation of posterior tibial fragments is hypothesized to restore syndesmotic stability, thereby reducing the reliance on trans-syndesmotic implants. Objective and Hypothesis:

The primary objective of this randomized controlled trial is to compare the rate of trans-syndesmotic stabilization device usage between patients undergoing osteosynthesis of posterior marginal fragments and those managed without posterior fragment osteosynthesis. The hypothesis is that syndesmotic stability (defined as non-use of a trans-syndesmotic device intraoperatively) will be significantly higher in the posterior fragment fixation group. Study Design:

Multicenter, open-label, randomized, two-arm parallel-group trial conducted at two orthopedic trauma centers (Groupe Hospitalier Diaconesses Croix Saint-Simon and Hôpital Lariboisière).

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Groupe hospitalier Diaconesses Croix Saint Simon

Paris, 75020, France

About this study

Study Flow and Procedures:

Screening and Randomization: Eligible patients presenting with recent bimalleolar ankle fractures (< 3 weeks) involving the posterior marginal fragment and syndesmosis (Bartoníček types 2, 3, or 4) are identified in the emergency/trauma department. Following written informed consent, participants are randomized into Group 1 (posterior marginal fragment osteosynthesis) or Group 2 (no posterior fragment osteosynthesis).

Preoperative Assessment: Comparative bilateral ankle X-rays and CT scans to confirm fracture classification and baseline metrics (fragment thickness > 2 mm, height > 6 mm).

Intraoperative Phase: Surgical management of the bimalleolar fracture according to assigned group. Intraoperative stress testing of the syndesmosis is performed to evaluate stability and record the necessity of trans-syndesmotic device placement.

Postoperative Follow-up: Day 1 to Week 6: Comparative bilateral CT scan to evaluate fragment and syndesmosis reduction. 3 Months & 12 Months: Clinical follow-up visits including comparative weight-bearing X-rays, evaluation of AOFAS score, and patient-reported questionnaires (MOXFQ, SF-12).

Postoperative complications (infections, neuropathic pain, fibular pain, flexor hallucis longus tendonitis) are systematically recorded throughout the 12-month follow-up.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient informed and written consent obtained
  • Male or female participants aged 18 years or older
  • Recent first-time ankle fracture (< 3 weeks prior to inclusion) involving the posterior marginal fragment and syndesmosis (Bartoníček 2, 3, or 4) confirmed on preoperative CT scan
  • Fractured posterior marginal fragment with thickness > 2 mm and height > 6 mm in the sagittal plane on preoperative CT scan

Exclusion criteria

  • Medical contraindication to surgery as assessed by the investigator based on risk-benefit evaluation
  • High Tscherne grade soft-tissue injury score
  • Recent lower-extremity surgery within the past 3 months
  • Recurrent ankle fracture on the same side
  • Patient deprived of liberty by judicial or administrative order
  • Patient not affiliated with or beneficiary of a national social security scheme
  • Patient unable to understand spoken or written French
  • Patient whose geographical residence is incompatible with close in-person study follow-up
  • Adult patient unable or unfit to give informed consent
  • Woman of childbearing potential not using effective contraception
  • Pregnant or breastfeeding woman

Treatment and study plan

Surgical management of bimalleolar ankle fractures with osteosynthesis of the posterior fragments.

Procedure

Surgical management of bimalleolar ankle fractures with osteosynthesis of the posterior fragments

Surgical management of bimalleolar ankle fractures without osteosynthesis of the posterior fragments

Procedure

Surgical management of bimalleolar ankle fractures without osteosynthesis of the posterior fragments.

Primary outcomes

  1. Rate of Intraoperative Trans-Syndesmotic Stabilization Device Use

    Time frame: ntraoperative (Day 0)

    Proportion of patients requiring the intraoperative placement of a trans-syndesmotic stabilization device (such as a screw, endobutton, or plate) to achieve syndesmotic stability, as assessed during surgery following stress testing.

Secondary outcomes

  1. American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Score

    Time frame: 3 months and 12 months postoperatively

    Clinical and functional assessment score combining pain, function, and alignment. The total score ranges from 0 to 100 points, where 0 represents severe disability/pain and 100 represents optimal function and no pain. Higher scores indicate better clinical outcome.

  2. Manchester-Oxford Foot Questionnaire (MOXFQ) Total Score

    Time frame: 3 months and 12 months postoperatively

    Patient-reported outcome measure assessing foot/ankle pain, walking/standing difficulties, and social interaction. The metric is converted to a score ranging from 0 to 100, where 0 represents no symptoms/best health state and 100 represents severe impairment. Higher scores indicate worse symptoms.

  3. Short Form-12 (SF-12) Physical and Mental Component Summary Scores

    Time frame: 3 months and 12 months postoperatively

    Patient-reported general health survey generating a Physical Component Summary (PCS) and Mental Component Summary (MCS) score. Norm-based scores range from 0 to 100, where higher scores indicate better health status.

  4. Postoperative Posterior Marginal Fragment and Syndesmosis Reduction Quality by CT Scan

    Time frame: Between Postoperative Day 1 and Week 6

    Assessment of posterior marginal fragment reduction quality and syndesmosis reduction (measuring fibular rotation, anterior and posterior tibiofibular distances, and anteroposterior translation) evaluated on postoperative CT scans.

  5. Radiographic Parameters of Syndesmosis Alignment on Weight-Bearing X-rays

    Time frame: 3 months and 12 months postoperatively

    Radiographic assessment of syndesmotic reduction on weight-bearing comparative X-rays, including medial clear space, tibiofibular clear space, tibiofibular overlap, and fibular length.

  6. Incidence of Postoperative Complications

    Time frame: Through 12 months postoperatively

    Proportion of patients experiencing surgery-related complications, including surgical site infections, neuropathic pain, fibular pain, or flexor hallucis longus pain.

Sponsors and collaborators

Lead sponsor

Groupe Hospitalier Diaconesses Croix Saint-Simon

Other

Registry information

Acronym: SYNDESMOSE

Important dates

Study start
2025
Primary completion
2028
Study completion
2029
First posted
Aug 10, 2026
Registry last updated
Aug 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.